Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
The Supreme Court on Monday sought the Centre’s response on a PIL accusing multinational pharma giant Glaxo Smithkline of having conducted unauthorised trials of its cancer vaccine on tribal girls. A bench headed by Justice KS Radhakrishnan, while seeking reply from the health ministry, also directed the Christian Medical College, …
Scientists at the Indian Institute of Science (IISc) have discovered a new molecule that, they say, could potentially lead to an anti-cancer drug, which may help reduce the dosage of current treatment methods like chemotherapy or radiotherapy. The molecule, aimed at killing cancer cells by blocking their DNA repair mechanism, …
Its healthcare system crippled by international economic sanctions, Iran has asked India for help to procure life-saving drugs for patients battling critical illnesses in that country. Tehran has put in an urgent request to New Delhi for drugs to treat lung and breast cancers; brain tumours; heart ailments; infections after …
Active against drug-resistant forms, the FDA-approved drug is a game changer While there is a lot of hope and enthusiasm over the new tuberculosis drug, first in close to 50 years, health activists say the challenge for countries like India and treatment providers is devising new treatment regimens for drug-resistant …
Pulls up Centre for failure to check malpractices by MNCs The Supreme Court on Thursday directed that until further orders all clinical trials on drugs will have to be conducted under the direct supervision of the Union Health Secretary to prevent illegal trials by pharmaceutical companies. A Bench of Justices …
The Planning Commission has set a target for the pharmaceutical industry to reach $100 billion by 2020 and account for five per cent share of the global drug industry in the next five years. According to the final draft of the 12th Five-Year Plan (2012-17) by the panel, the objective …
Increasing the heat on Chinese drug firms exporting medicines to India, the Drug Controller General of India (DCGI) is all set to open its first foreign drug inspection office in Beijing by March 1. Around four Indian drug inspectors will be posted in China to inspect manufacturing sites and check …
Analysts say the new mechanism would impact revenues in the short term only The Indian pharmaceutical industry is likely to see a dip in valuations in the near term as a result of the recent pricing policy that aims to intensify the regulatory hold over essential drugs. Profit of major …
India’s vaccine manufacturing sector is set for massive export boost with the country’s national regulatory authority, the Central Drugs Standard Control Organisation (CDSCO), passing the WHO’s toughest efficacy and safety tests. An 18-member team of drug inspectors from the WHO, US-FDA, Sweden, China, Switzerland and Thailand reviewed the Central Drug …
12 units from India are eligible for supplying vaccines to international bodies In a major boost to the country’s private vaccine manufacturing pharmaceutical companies, the World Health Organisation (WHO) has said that India’s national regulatory authority — Central Drugs Standard Control Organisation (CDSCO) — and its affiliated institutions meet the …
The government today said the new drug policy which aims at bringing more medicines under price control has been notified. "The National Pharmaceutical Pricing Policy (NPPP-2012) approved by the Cabinet on November 22, 2012 has been notified on December 7, 2012," Minister of State for Chemicals and Fertilisers Srikant Kumar …
Prices of drugs that are defined as essential under the existing policy, but will not remain so under the new pharma pricing policy, would be frozen for a year, after which pharmaceutical firms would be allowed to increase prices at the rate of not more than 10% every year. For …
In a bid to ensure that the drugs available in the country are safe for consumption, the Drug Controller-General of India (DCGI) has asked the state drug inspectors to get the samples of the drugs collected and get them tested for their quality at the drug testing laboratories. The issue …
Hyderabad: As the government is planning to go liberal regarding the environmental violations by bulk drug units, the international community has taken up cudgels against the pollution caused by them. Professor Hans Lofgren, of the Deakin University of Australia said that he will make a representation to his government to …
The government has finalised the National Pharmaceuticals Pricing Policy 2012, which would replace the Drugs (Price Control) Order, 1994 that currently monitors and regulates prices of essential medicines in the country. The National Pharmaceuticals Pricing Policy, 2012 seeks to regulate drug prices on the basis of essentiality of the drug …
Sandoz, the generic arm of Swiss drug maker Novartis, has decided to shut its facility for development of generic drugs in India. The facility, known as Sandoz Development Centre located near Mumbai, employed around 157 people, who are now given notice till February, sources, close to the development, told Business …
It was the most expensive foreign acquisition by an Indian company in 2006. Dr Reddy’s Laboratories had gone to town with its trophy, German branded generics company Betapharm, acquired for $560 million (Rs 2,550 crore). Six years later, the valuation of Betapharm in the company’s balance sheet is just $108 …
French pharma giant Sanofi Pasteur is conducting phase-3 trial of a vaccine for dengue in five cities across the country including Bangalore, the government informed the Lok Sabha on Friday. “The trial is being conducted in Bangalore, Ludhiana, Kolkata, Pune and Delhi. If it passes the third and fast clinical …
Frankfurt: A new-age singledose vaccine with over 90% protection rate against Japanese Encephalitis (JE), which kills thousands of Indian children every year, will soon be available in the country. The vaccine Imojev, made by French pharma giant Sanofi Pasteur, can be used for immunization of those 12 months and older. …
